Thursday January 01, 1970
The 2024 health care service M&A landscape
Is 2024 the year that deals return? After a significant slow down in M&A for more than a year a smattering of large deals at the end of 2023 breathed hope of recovery in the market. Will 2024 be a see a return in transactions and IPOs? Will sellers be forced to accept lower valuations? What sectors and business models are most attractive? How are deals being financed and what is the impact on debt maturity?
Hedley Goldberg, Partner, Rothschild & Co



The 2024 health care service M&A landscape
Is 2024 the year that deals return? After a significant slow down in M&A for more than a year a smattering of large deals at the end of 2023 breathed hope of recovery in the market. Will 2024 be a see a return in transactions and IPOs? Will sellers be forced to accept lower valuations? What sectors and business models are most attractive? How are deals being financed and what is the impact on debt maturity?
Hedley Goldberg, Partner, Rothschild & Co
Speakers



Explore similar sessions
Sector in focus: Lab diagnostics
With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively?...
Sector in focus: Lab diagnostics
With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively? Is there a threat from blood testing start-ups that are like Theranos, but work? This session features three laboratory diagnostic CEOs who share their approaches to growth.
Speakers
The new healthcare powerhouse: MENA
The Middle East, particularly the UAE and Saudi Arabia are dominating headlines. Be it Abu Dhabi’s Pure Health’s acquisition of Circle or the gigantic PPP projects of Saudi’s Vision 2030,...
The new healthcare powerhouse: MENA
The Middle East, particularly the UAE and Saudi Arabia are dominating headlines. Be it Abu Dhabi’s Pure Health’s acquisition of Circle or the gigantic PPP projects of Saudi’s Vision 2030, there is a buzz of excitement from investors and providers, but still a large amount of uncertainty. This session, together with a detailed market overview, brings together providers and investors from MENA to discuss what the opportunity is and the best strategies to pursue them.
Speakers
Investing in health care property
A conversation with some of the largest health care property investors discussing topics such as: How robust is health care real estate to rising inflation? What ESG frameworks are in...
Investing in health care property
A conversation with some of the largest health care property investors discussing topics such as: How robust is health care real estate to rising inflation? What ESG frameworks are in place and what is lacking? What impact is the lack of available debt having on transactions?